Privia Health Group Inc (NAS:PRVA)

Q2 2026 Privia Health Group Inc Earnings Call Transcript

Aug 6, 2026 / 12:00 PM GMT

Release Date Price: $22 (-8.18%)

Transcript 10-Q8-K

Key Points

Positve

Privia Health Group Inc (PRVA) delivered strong operational execution with implemented provider growth of 10.1% and value-based attributed lives growth of 19.2% year-over-year, driving total practice collections growth of 12.4% in Q2 2026.
Adjusted EBITDA increased 29% year-over-year, with EBITDA margin as a percentage of care margin expanding 310 basis points, demonstrating significant operating leverage.
The company raised its 2026 outlook across all key financial metrics, including practice collections, care margin, and EBITDA, due to strong first-half performance and attributed lives above the high end of prior guidance.
Privia Health Group Inc (PRVA) expanded into its 25th state with the entry into New Jersey, partnering with Neurology Group of Bergen County, and maintains a robust pipeline for further market expansion.
The company is deploying AI applications across four workflows (corporate, fee-for-service, value-based, and patient care), which is expected to drive EBITDA margin towards the high end of its 30-35% long-term target range.
Privia Health Group Inc (PRVA) maintains a strong balance sheet with over $412 million in cash and no debt, providing significant financial flexibility for capital deployment and acquisitions.
The company's diversified value-based care portfolio, including commercial, Medicare Advantage, and Medicaid contracts, reduces dependence on any single program and supports sustainable growth.
Gross provider retention averaged 98% over the past three years, reflecting the strength of the company's integrated model and partner value proposition.

Negative

CMS proposed changes to the Medicare Shared Savings Program for performance year 2025 may delay final reconciliation results until November, potentially leading to an atypical year-end cash flow dynamic.
The company's updated guidance implies a significant deceleration in practice collections growth in the second half of 2026 (around 3% year-over-year) compared to 13% in the first half, which management attributes to conservatism but could signal headwinds.
Provider expenses increased to $500 million in the quarter, growing faster than revenue and exceeding some expectations, though management attributes this to pass-through payments reflecting business growth.
Privia Health Group Inc (PRVA) is now a full cash taxpayer starting in 2026, which could impact free cash flow conversion, expected at 70-80% of adjusted EBITDA.
The company's entry into New Jersey is with a small initial practice (25 clinicians), and management notes it will be a 5-10 year play, indicating limited near-term contribution to financial metrics.
The transition from ACO REACH to the new ACO LEAD program creates market disruption, and while it presents opportunities, it also introduces uncertainty in the ACO-only business model.
Management acknowledged that the long-term EBITDA growth target of 20% could be revisited, but they continue to guide to that level despite recent performance averaging 32%, suggesting potential for underperformance in some years.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PRVA.OQ - Privia Health Group Inc
Q2 2026 Privia Health Group Inc Earnings Call
Aug 06, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by and welcome to Privia Health's second quarter, 2026, earnings conference call.

Currently, all participants are in a listen-only mode.

After the speaker's presentation, there will be a question-and-answer session.

To ask a question during the session, you will need to press star 11 on your telephone.

To remove yourself from the queue, you may pressar 11 again.

I would now like to hand the call over to Robert Bouchert, SVP of Investor and Corporate communications, please go ahead.

Thank you, Latif, joining me are CEO Parth Merotra and David Mountcast, our Chief Financial Officer, this call is being webcast and can be accessed in the investor

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.